Insider filing · ASPE
Peter A. Thompson
Director
profile →
Aspen Neuroscience, Inc.
ASPE · Healthcare · 4 filings in 24 months
ticker →
Peter A. Thompson bought $15.0M of Aspen Neuroscience (ASPE)
Executed Nov 2, disclosed Nov 4, 2 days later.
Value, as filed
$15.0M
1,000,000 sh × $15.00
Executed
Nov 2
the trade date, as filed
Disclosed
Nov 4
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
not yet measured
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
The filer
PTPeter A. Thompson (Director) filed 9 Form 4 reports in the trailing twelve months (1 purchase, 8 sales), most often in Sionna Therapeutics, Inc. (SION). The largest single filing was $22.9M of SION (510,583 sh across 3 lots, as filed), executed Apr 14. The median gap between execution and disclosure was 2 days.
The name
ASPEHealthcare · Aspen Neuroscience, Inc. develops autologous induced pluripotent stem cell (iPSC)-derived cell replacement therapies for neurodegenerative…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→